Andrew Bab, M&A partner at Debevoise & Plimpton LLP, is advising J.P. Morgan Securities LLC as financial advisor to PPD Inc., (NASDAQ: PPD) in its sale to Thermo Fisher (NYSE: TMO) for $17.4 billion in cash plus $3.5 billion of net debt. For more information, please see the company’s press release. Read More>

Debevoise & Plimpton LLP is advising Deutsche Bank Securities as financial advisor to Bally’s Corporation (NYSE: BALY) in its combination with Gamesys Group plc. The combination marks a transformational step in both companies’ long-term growth strategies and positions Bally’s to become a leading omni-channel gaming entity. For more information please see the press release from Bally’s. Read More>

Debevoise & Plimpton LLP is advising funds managed by Blackstone Growth as co-investors in the formation of Hydrogen Health, LLC, alongside K Health. The joint venture is also backed by an investment from Anthem, Inc. (ANTM) and is an important step in seeking to help increase access to healthcare services and make healthcare more affordable for millions of people in the U.S. For more information, please see the press release announcing the joint venture. Read More>

Debevoise & Plimpton LLP is advising Kelso & Company in its acquisition of Ferraro Foods, a portfolio company of Kainos Capital, a food and consumer-focused private equity firm. For more information, please see the company’s press release. Read More>

Debevoise & Plimpton LLP is advising J.P. Morgan Securities LLC as financial advisor to Magnachip Semiconductor Corporation (NYSE: MX), in Magnachip’s agreement to be acquired by investment vehicles established by Wise Road Capital LTD and certain of its limited partners. The all-cash transaction has an equity value of approximately $1.4 billion. For more information, please see Magnachip’s press release. Read More>